Antonio Colombo

Summary

Affiliation: EMO Centro Cuore Columbus
Country: Italy

Publications

  1. ncbi Percutaneous valve replacement in a young adult for radiation-induced aortic stenosis
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, 48 Via M Buonarroti, Milan, Italy
    J Cardiovasc Med (Hagerstown) 13:397-8. 2012
  2. ncbi A new technique for coronary bifurcations: good news!
    Antonio Colombo
    EMO Centro Cuore Columbus, Via M. Buonarroti 48, 20145, Milan, Italy
    J Invasive Cardiol 15:184-5. 2003
  3. ncbi Interventional cardiology: does stent overlap make a difference to clinical outcome?
    Antonio Colombo
    Interventional Cardiology Unit, EMO GVM Centro Cuore Columbus Hospital, Via Buonarroti 48, 20145 Milan, Italy
    Nat Rev Cardiol 7:362-4. 2010
  4. ncbi Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    Circulation 107:2178-80. 2003
  5. ncbi Contemporary treatment of coronary bifurcations with drug-eluting stent: part II
    Antonio Colombo
    EMO Centro Cuore Columbus, San Raffaele Hospital, Milan, Italy
    J Interv Cardiol 19:51-3. 2006
  6. ncbi Effectiveness of treatment of in-stent restenosis with an 8-French compatible atherectomy catheter
    Flavio Airoldi
    EMO Centro Cuore, Columbus Clinic, Via Buonarroti 48 20145 Milan, Italy
    Am J Cardiol 92:725-8. 2003
  7. ncbi Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    Catheter Cardiovasc Interv 60:145-51. 2003
  8. ncbi Passive coating: the dream does not come true
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    J Invasive Cardiol 15:566-7. 2003
  9. ncbi Using intravascular ultrasound with drug-eluting stents. What have we learned so far?
    V Spanos
    EMO Centro Cuore Columbus, Milan, Italy
    Minerva Cardioangiol 51:493-505, 505-11. 2003
  10. ncbi Bifurcation lesions
    Antonio Colombo
    EMO Centro Cuore Columbus, and Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy
    Ital Heart J 6:475-88. 2005

Detail Information

Publications113 found, 100 shown here

  1. ncbi Percutaneous valve replacement in a young adult for radiation-induced aortic stenosis
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, 48 Via M Buonarroti, Milan, Italy
    J Cardiovasc Med (Hagerstown) 13:397-8. 2012
    ..The final result was excellent with reduction of the transaortic gradient and no residual aortic regurgitation...
  2. ncbi A new technique for coronary bifurcations: good news!
    Antonio Colombo
    EMO Centro Cuore Columbus, Via M. Buonarroti 48, 20145, Milan, Italy
    J Invasive Cardiol 15:184-5. 2003
  3. ncbi Interventional cardiology: does stent overlap make a difference to clinical outcome?
    Antonio Colombo
    Interventional Cardiology Unit, EMO GVM Centro Cuore Columbus Hospital, Via Buonarroti 48, 20145 Milan, Italy
    Nat Rev Cardiol 7:362-4. 2010
    ....
  4. ncbi Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    Circulation 107:2178-80. 2003
    ..Restenosis after implantation of drug-eluting stents (DES) is a rare phenomenon, occurring more frequently peri-stent...
  5. ncbi Contemporary treatment of coronary bifurcations with drug-eluting stent: part II
    Antonio Colombo
    EMO Centro Cuore Columbus, San Raffaele Hospital, Milan, Italy
    J Interv Cardiol 19:51-3. 2006
  6. ncbi Effectiveness of treatment of in-stent restenosis with an 8-French compatible atherectomy catheter
    Flavio Airoldi
    EMO Centro Cuore, Columbus Clinic, Via Buonarroti 48 20145 Milan, Italy
    Am J Cardiol 92:725-8. 2003
    ..6% of patients. The secondary end point regarding the incidence of angiographic restenosis at 6 months showed a high restenosis rate (65%)...
  7. ncbi Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    Catheter Cardiovasc Interv 60:145-51. 2003
    ..Angiographic follow-up is necessary to prove the advantage of this specific technique to give complete coverage of the ostium of the side branch with a drug-eluting stent...
  8. ncbi Passive coating: the dream does not come true
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    J Invasive Cardiol 15:566-7. 2003
  9. ncbi Using intravascular ultrasound with drug-eluting stents. What have we learned so far?
    V Spanos
    EMO Centro Cuore Columbus, Milan, Italy
    Minerva Cardioangiol 51:493-505, 505-11. 2003
    ..The overall clinical importance of IVUS in the new era will depend on the amount and the clinical significance of any unsolved questions we will face and on its ability to provide answers to the evolving questions...
  10. ncbi Bifurcation lesions
    Antonio Colombo
    EMO Centro Cuore Columbus, and Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy
    Ital Heart J 6:475-88. 2005
    ....
  11. ncbi Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome
    Lei Ge
    EMO Centro Cuore Columbus, 48 Via M Buonarroti, 20145 Milan, Italy
    J Am Coll Cardiol 45:989-94. 2005
    ..The purpose of the present report was to evaluate clinical and angiographic outcomes of drug-eluting stent (DES) implantation in saphenous vein graft (SVG) lesions...
  12. ncbi Another trick to improve the safety of transseptal puncture
    Antonio Colombo
    EMO, Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    J Invasive Cardiol 17:71-2. 2005
  13. ncbi Concurrent implantation of sirolimus- and paclitaxel-eluting stents in the same vessel
    Simon J Corbett
    EMO Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 69:109-14. 2007
    ..To assess the safety and efficacy of concurrent implantation of sirolimus-eluting (SES) and paclitaxel-eluting (PES) stents in the same coronary artery...
  14. ncbi Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease)
    Antonio Colombo
    San Raffaele Scientific Institute and EMO Centro Cuore Columbus, 20145 Milan, Italy
    Circulation 116:1424-32. 2007
  15. ncbi Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents
    Goran Stankovic
    EMO Centro Cuore Columbus, 48 Via Buonarroti, 20145 Milan, Italy
    Am J Cardiol 93:1397-401, A9. 2004
    ..The total stent length per patient (predisposing factor) and elective use of glycoprotein IIb/IIIa (protective factor) were independent predictors of increased creatine kinase-MB isoenzyme levels...
  16. ncbi Selection of coronary stents
    Antonio Colombo
    Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 40:1021-33. 2002
    ....
  17. ncbi Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study
    Antonio Colombo
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Circulation 119:71-8. 2009
    ..Sirolimus-eluting stents have been reported to be effective in the treatment of coronary bifurcations. Still, it has not been fully clarified which strategy would provide the best results with true bifurcation lesions...
  18. ncbi Bifurcation stenting: current strategies and new devices
    A Latib
    EMO Centro Cuore Columbus, Milan, Italy
    Heart 95:495-504. 2009
    ..The development of more drug-eluting platforms and larger studies with control groups demonstrating their clinical applicability, efficacy and safety are required before they are widely incorporated into daily practice...
  19. ncbi Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results
    Dejan Orlic
    EMO, Centro Cuore Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 43:1154-60. 2004
    ..CONCLUSIONS: Multivessel SES implantation can be safely performed on patients with complex coronary artery disease. The need for revascularization increases because of the cumulative effect of TLR on patients with multiple lesions...
  20. ncbi Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions
    John Cosgrave
    EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    Am J Cardiol 96:1663-8. 2005
    ..Overall, the 2 available stent platforms had similar performance characteristics...
  21. ncbi Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era
    Giuseppe G L Biondi-Zoccai
    St. Raffaele Hospital, Milan, Italy
    Am J Cardiol 95:1466-8. 2005
    ..Such results may provide useful information to guide prevention of this complication...
  22. ncbi Prolonged double antiplatelet therapy in a cohort of "de novo" diabetic patients treated with drug-eluting stent implantation
    Nadia Mollichelli
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 105:1395-401. 2010
    ..42, 95% confidence interval 4.99 to 83.62). In conclusion, DM remains an independent adverse factor on clinical outcome. In this setting, prolonged DAT, even beyond that recommended in the guidelines, might be beneficial...
  23. ncbi Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions
    Lei Ge
    EMO Centro Cuore Columbus and San Raffaele Hospital, 48 Via M. Buonarroti, 20145 Milan, Italy
    Eur Heart J 26:1056-62. 2005
    ..CONCLUSION: Compared with BMS, SES implantation in CTO lesions appears to be effective in reducing the incidence of restenosis and the need for revascularization at 6 months...
  24. ncbi Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation
    Kensuke Takagi
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Catheter Cardiovasc Interv 78:432-43. 2011
    ..To investigate the predictors of moderate-to-severe aortic regurgitation (AR≥2+) after CoreValve implantation and evaluate the feasibility and safety of postdilatation in reducing the degree of AR...
  25. ncbi Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience
    Cosmo Godino
    Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy
    JACC Cardiovasc Interv 3:1110-21. 2010
    ..Our aim was to assess clinical outcome after transcatheter aortic valve implantation (TAVI) performed with the 2 commercially available valves with 3 delivery approaches selected in a stepwise fashion...
  26. ncbi 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience
    Alaide Chieffo
    Interventional Cardiology Unit, Department of Cardio Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 3:595-601. 2010
    ....
  27. ncbi Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)
    Cosmo Godino
    San Raffaele Institute, Milan, Italy
    EuroIntervention 5:906-16. 2010
    ..The objective of this study was to evaluate "real world" long-term outcome following paclitaxel-eluting stent (PES) implantation for unprotected LMCA disease in patients enrolled in the TRUE registry...
  28. ncbi Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation
    Rasha Al-Lamee
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 4:87-95. 2011
    ..The aim of this study was to evaluate the incidence, predictors, management, and clinical outcomes in patients with grade III coronary perforation during percutaneous coronary intervention...
  29. ncbi Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique
    Antonio Colombo
    Catheterization Laboratory, San Raffaele Hospital, Milan, Italy
    Catheter Cardiovasc Interv 64:407-11; discussion 412. 2005
    ..This technique appears a promising approach to recanalize difficult total occlusions, particularly the ones localize on the RCA, which has the most important side branches located distally...
  30. ncbi A new technique for vascular access management in transcatheter aortic valve implantation
    Andrew S P Sharp
    San Raffaele Scientific Institute and Columbus Hospitals, Milan, Italy
    Catheter Cardiovasc Interv 75:784-93. 2010
    ..To describe results from a novel percutaneous technique designed to minimize the risk of hemorrhage in the event of a major complication during transcatheter aortic valve implantation...
  31. ncbi Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis
    Flavio Airoldi
    San Raffaele Hospital IRCCS, Milan, Italy
    Am J Cardiol 97:1182-7. 2006
    ..The association of diffuse restenosis and diabetes mellitus is an unfavorable condition leading to a high risk of recurrence...
  32. ncbi Insulin-treated diabetes mellitus and predictors of mid-term clinical outcome after percutaneous coronary interventions with stent implantation
    Giuseppe Tarantini
    EMO Centro Cuore Columbus, San Raffaele Hospital, Milan, Italy
    Ital Heart J 4:843-9. 2003
    ..The predictors of outcome in such patients after coronary stenting have not been clarified...
  33. ncbi Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    Am Heart J 153:354-9. 2007
    ..Currently, little data are available on the management of drug-eluting stent (DES) restenosis. Drug resistance may play a role in its etiology...
  34. ncbi Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents
    Pierfrancesco Agostoni
    San Raffaele Hospital, Milan, Italy
    Am J Cardiol 99:593-8. 2007
    ..Thus, late loss may not be a reliable marker of the true efficacy of these devices due to its complex and nongaussian distribution...
  35. ncbi Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 4:155-64. 2011
    ..This study sought to evaluate the long-term angiographic and clinical outcomes after the treatment of drug-eluting stent in-stent restenosis (DES-ISR) based on the angiographic pattern of restenosis...
  36. ncbi Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 49:2320-8. 2007
    ..This study was designed to compare the outcomes of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) in a contemporaneous cohort of real-world patients...
  37. ncbi Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates
    Maurizio Taramasso
    Cardiothoracic Department, San Raffaele Scientific Institute, Milan, Italy
    EuroIntervention 8:429-36. 2012
    ..The aim of the study was to investigate the changes in quality of life (QoL) following transcatheter aortic valve implantation (TAVI) up to two years' follow-up...
  38. ncbi Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside
    Flavio Airoldi
    San Raffaele Hospital IRCCS, Milan, Italy
    Am J Cardiol 99:916-20. 2007
    ..In conclusion, the standardized protocol of intracoronary NTP administration succeeded in normalizing SCF in all patients with AMI but in only 5 of 9 patients with SVG stenosis. This latter subgroup requires other therapeutic strategies...
  39. ncbi Incidence of overall bleeding in patients treated with intra-aortic balloon pump during percutaneous coronary intervention: 12-year Milan experience
    Giedrius Davidavicius
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 5:350-7. 2012
    ....
  40. ncbi Is overdilatation of 3.0 mm sirolimus-eluting stent associated with a higher restenosis rate?
    Ioannis Iakovou
    EMO, Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 64:129-33. 2005
    ..These data should lessen concern that overdilation may dilute the beneficial effects of SESs...
  41. ncbi Early and mid-term results of drug-eluting stent implantation in unprotected left main
    Alaide Chieffo
    San Raffaele Hospital, Milan, Italy
    Circulation 111:791-5. 2005
    ..A randomized study comparing surgery appears justified at present...
  42. ncbi Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial
    Goran Stankovic
    Columbus Hospital, Milan, Italy
    Circulation 108:37-42. 2003
    ..However, a higher incidence of nonfatal myocardial infarctions was found in patients treated with the PTFE-covered stent...
  43. ncbi Clinical outcomes following protected carotid artery stenting in symptomatic and asymptomatic patients
    Alfonso Ielasi
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    J Endovasc Ther 17:298-307. 2010
    ..To evaluate clinical outcomes in patients undergoing carotid artery stenting (CAS) with routine use of a cerebral embolic protection device (EPD)...
  44. ncbi Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery
    Eleftheria Tsagalou
    San Raffaele Hospital, Milan, Italy
    J Am Coll Cardiol 45:1570-3. 2005
    ..CONCLUSIONS: The implantation of multiple overlapping DES in patients with a diffusely diseased LAD is relatively safe and associated with good midterm clinical outcomes...
  45. ncbi Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy
    Eur Heart J 27:540-6. 2006
    ....
  46. ncbi A high dose of adenosine to induce transient asystole for valvuloplasty in patients undergoing transcatheter aortic valve implantation (TAVI): is it a valid alternative to rapid pacing? A prospective pilot study
    Giedrius Davidavicius
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    J Invasive Cardiol 23:467-71. 2011
    ..A risk of inducing myocardial ischemia with RRVP remains, especially in patients with left ventricular dysfunction. Alternatively, a transient cardiac arrest can be achieved with administration of adenosine...
  47. ncbi Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions
    Antonio Colombo
    EMO Centro Cuore Columbus, Milan, Italy
    Circulation 109:1244-9. 2004
    ..Restenosis at the SB remains a problem. At this time, no statement can be made regarding the most appropriate technique to use when treating bifurcations with the Cypher stent...
  48. ncbi Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    EuroIntervention 7:1275-84. 2012
    ..Transcatheter valve-in-valve (VIV) implantation may offer a less invasive alternative. The aim of this study was to report our initial experience with transcatheter VIV implantation to treat degenerated tissue valves...
  49. ncbi Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions
    Shinichi Furuichi
    Invasive Cardiology Unit, San Raffaele Scientific Institute and EMO Centro Cuore Columbus, Milan, Italy
    EuroIntervention 5:370-4. 2009
    ..The aim of this study was to evaluate the outcome of patients with severe lesion calcification undergoing RA followed by implantation of DES...
  50. ncbi Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
    Flavio Airoldi
    Invasive Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Circulation 116:745-54. 2007
    ..The need for prolonged aspirin and thienopyridine therapy and the risk of stent thrombosis (ST) remain as drawbacks associated with drug-eluting stents...
  51. ncbi Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans
    Renu Virmani
    Catheterization Laboratories, Ospedale San Raffaele and Emo Centro Cuore Columbus, Milan, Italy
    Circulation 106:2649-51. 2002
    ..This study presents the histological findings of atherectomy specimens from a subset of these patients receiving implants...
  52. ncbi Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation
    Renata Rogacka
    San Raffaele Scientific Institute, Via Olgettina 60, Milan, Italy
    JACC Cardiovasc Interv 1:56-61. 2008
    ..The purpose of this study was to evaluate the safety of dual antiplatelet therapy in patients in whom long-term anticoagulation (AC) with warfarin is recommended...
  53. ncbi Late restenosis following sirolimus-eluting stent implantation
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 100:41-4. 2007
    ..In conclusion, late restenosis is an infrequent but real entity; its existence implies we should not discount the possibility of restenosis as the cause of symptoms that develop >1 year after sirolimus-eluting stent implantation...
  54. ncbi Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents
    Eleftheria Tsagalou
    The San Raffaele Hospital, Milan, Italy
    Am J Cardiol 97:187-91. 2006
    ..93 mm, p = 0.0001) in the DES group. In conclusion, DES implantation in de novo ostial LAD lesions appears safe and effective and is associated with a significant decrease in restenotic rates compared with historical experience with BMSs...
  55. ncbi Initial experience with a new 8 French-compatible directional atherectomy catheter: immediate and mid-term results
    Dejan Orlic
    Catheterization Laboratory, Columbus Hospital, Milan, Italy
    Catheter Cardiovasc Interv 60:159-66. 2003
    ..Plaque debulking with the FHT catheter can be performed safely and effectively in relatively small vessels and complex lesions located in mid-distal artery segments with 6-month clinical outcome similar to prior atherectomy devices...
  56. ncbi Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease
    Flavio Airoldi
    EMO Centro Cuore, Columbus Hospital, Milan, Italy
    Am J Cardiol 93:474-7. 2004
    ..5% in the CC group vs 32.7% in the SS group; p = 0.675). In unselected patients and lesions, carbon coating does not provide significant improvements over SS stents with the same design...
  57. ncbi Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure
    Ioannis Iakovou
    EMO Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 94:351-4. 2004
    ....
  58. ncbi Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation
    Lei Ge
    EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    J Am Coll Cardiol 46:613-20. 2005
    ..CONCLUSIONS: Compared to the absence of FKB, the "crush" stenting technique with FKB appears to be associated with more favorable long-term outcomes. When utilizing the "crush" stenting technique, FKB is mandatory...
  59. ncbi Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
    Ioannis Iakovou
    Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    JAMA 293:2126-30. 2005
    ..Premature antiplatelet therapy discontinuation, renal failure, bifurcation lesions, diabetes, and low ejection fraction were identified as predictors of thrombotic events...
  60. ncbi Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient
    Ioannis Iakovou
    EMO Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 64:436-9; discussion 440-1. 2005
    ..Multiple (> or =4) SES implantation appears safe with no increase in major adverse cardiac events...
  61. ncbi The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry
    Gill Louise Buchanan
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    EuroIntervention 7:556-63. 2011
    ..To assess outcomes after transcatheter aortic valve implantation (TAVI) according to sex, with the two available valves and four recognised delivery approaches...
  62. ncbi Coronary chronic total occlusions: mid-term comparison of clinical outcome following the use of the guided-STAR technique and conventional anterograde approaches
    Cosmo Godino
    Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy
    Catheter Cardiovasc Interv 79:20-7. 2012
    ....
  63. ncbi Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve
    Marco Mussardo
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 4:743-50. 2011
    ..The aim of this study was to analyze the short-term outcomes after transcatheter aortic valve implantation with the Edwards Sapien THV (ESV), compared with the Sapien XT THV (SXT) (Edwards Lifesciences, Irvine, California)...
  64. ncbi Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry)
    Cosmo Godino
    Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy
    Am J Cardiol 102:1002-8. 2008
    ..The rate of subacute and late stent thrombosis was low in this subgroup of patients...
  65. ncbi Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques
    Rasha Al-Lamee
    San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 106:1721-7. 2010
    ..The repeat revascularization rates were high; however, graft patency was achievable in most after reintervention...
  66. ncbi Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience
    Alaide Chieffo
    Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy
    Circulation 113:2542-7. 2006
    ....
  67. ncbi Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations
    Goran Stankovic
    Columbus Hospital, Milan, Italy
    Am J Cardiol 93:213-6. 2004
    ..The incidence of adverse events, emergency coronary artery bypass grafting and death significantly decreased over time...
  68. ncbi Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery
    Takuro Takagi
    EMO Centro Cuore Columbus, Milan, Italy
    Circulation 106:698-702. 2002
    ..Reference vessel size and left ventricular function are the most important predictors of favorable follow-up...
  69. ncbi Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions
    Ioannis Iakovou
    Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 44:967-71. 2004
    ....
  70. ncbi Subintimal tracking and re-entry technique with contrast guidance: a safer approach
    Mauro Carlino
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    Catheter Cardiovasc Interv 72:790-6. 2008
    ..To assess the procedural and clinical outcomes from a modified subintimal tracking and re-entry (STAR) procedure performed using contrast guidance...
  71. ncbi Clinical outcomes after unrestricted implantation of everolimus-eluting stents
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 2:1219-26. 2009
    ..The aim of this study was to evaluate the efficacy and safety of unrestricted everolimus-eluting stent (EES) implantation in a contemporary cohort of real-world patients...
  72. ncbi In-stent restenosis in small coronary arteries: impact of strut thickness
    Carlo Briguori
    Laboratory of Interventional Cardiology, Vita e Salute University School of Medicine, San Raffaele Hospital, Milan, Italy
    J Am Coll Cardiol 40:403-9. 2002
    ..001) and diabetes mellitus (OR 2.10, 95% CI 1.21 to 3.68; p = 0.007). CONCLUSIONS: This study supports that strut thickness is an independent predictor of restenosis in coronary arteries with a reference diameter of 2.75 to 2.99 mm...
  73. ncbi Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents
    Simon J Corbett
    EMO Centro Cuore Columbus, 48 Via M. Buonarroti, 20145 Milan, Italy
    Eur Heart J 27:2330-7. 2006
    ..In contrast, just under half of restenosis in PES is the more severe non-focal pattern. Paradoxically, the majority of focal restenosis occurs at the proximal stent margin for both platforms...
  74. ncbi Drug-eluting stent restenosis the pattern predicts the outcome
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 47:2399-404. 2006
    ..CONCLUSIONS: Similar to bare-metal stent data, the angiographic pattern of restenosis following DES implantation is prognostically important. Diabetes is a significant predictor of the pattern of restenosis in the DES era...
  75. ncbi Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents
    Simon J Corbett
    EMO Centro Cuore Columbus, 20145 Milan, Italy
    Cardiovasc Revasc Med 7:159-64. 2006
    ..In this article, we review these data with the aim of placing the studies in context thereby providing an overall view of this rapidly developing field as it stands at present...
  76. ncbi Occlusion of the saphenous vein graft at the site of polytetrafluoroethylene membrane-covered stent implantation: was it late thrombosis?
    Konstantinos Toutouzas
    Centro Cuore Columbus, Milan, Italy
    J Invasive Cardiol 15:722-4. 2003
  77. ncbi Percutaneous coronary intervention in patients with a single remaining vessel
    Davide Tavano
    San Raffaele Scientific Institute, Milan, Italy
    Am J Cardiol 99:470-1. 2007
    ..In conclusion, these data support percutaneous intervention as a realistic treatment option for this often highly symptomatic and difficult-to-treat patient cohort...
  78. ncbi Bifurcation disease: what do we know, what should we do?
    Azeem Latib
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
    JACC Cardiovasc Interv 1:218-26. 2008
    ..Dedicated bifurcation stents are an exciting new technology that may further simplify the management of bifurcation PCI and change some of these concepts...
  79. ncbi Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform
    Nedy Brambilla
    Department of Interventional Cardiology, Sant Ambrogio Clinical Institute, Milan, Italy
    J Cardiovasc Med (Hagerstown) 10:852-8. 2009
    ....
  80. ncbi Outcome of nonobstructive residual dissections detected by intravascular ultrasound following percutaneous coronary intervention
    Takahiro Nishida
    EMO Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 89:1257-62. 2002
    ..Nonobstructive dissections can be left untreated when final IVUS reveals an area stenosis of < 60% at the site of a dissection...
  81. ncbi The lunar stent characteristics and clinical results
    Fabio Alfredo Sgura
    Department of Interventional Cardiology San Raffaele Hospital, Milan, Italy
    Herz 27:514-7. 2002
    ..Preliminary clinical and angiographic follow-up show a low rate of cardiac events at 6 months (16.1% MACE) and a moderate hyperplastic response...
  82. ncbi Outcome of treatment of aorto-ostial lesions involving the right coronary artery or a saphenous vein graft with a polytetrafluoroethylene-covered stent
    Konstantinos Toutouzas
    Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    Am J Cardiol 90:63-6. 2002
  83. ncbi A new dedicated stent and delivery system for the treatment of bifurcation lesions: preliminary experience
    Konstantinos Toutouzas
    Centro Cuore Columbus, Milan, Italy
    Catheter Cardiovasc Interv 58:34-42. 2003
    ..Treatment of bifurcation lesions with this new dedicated device appears to be feasible. This new device may introduce a new approach for the treatment of coronary bifurcation lesions...
  84. ncbi Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE)
    Giuseppe G L Biondi Zoccai
    Mediolanum Cardio Research, Milan, Italy
    Int J Cardiol 117:349-54. 2007
    ..Indeed, the TRUE Study, including as much as 115 ULM and 229 bifurcation interventions, should give important insights into the outcome of PES in such an unprecedented and challenging context...
  85. ncbi Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting
    Antonio Colombo
    EMO Centro Cuore Columbus and San Raffaele Hospitals, Milan, Italy
    Catheter Cardiovasc Interv 63:61-2. 2004
  86. ncbi Does IVUS guidance of coronary interventions affect outcome? a prime example of the failure of randomized clinical trials
    Robert Gerber
    EMO Centro Cuore Columbus and San Raffaele Hospitals, Milan, Italy
    Catheter Cardiovasc Interv 71:646-54. 2008
    ..We hope to demonstrate this statement with the completion of the angiographically versus IVUS optimization (AVIO) study that soon will be initiated...
  87. ncbi Modern strategies to prevent coronary restenosis
    Alaide Chieffo
    Laboratory of Interventional Cardiology, EMO Centro Cuore Columbus, Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy
    Ital Heart J 3:9S-15S. 2002
  88. ncbi Sidebranch patency during main branch stenting: try to keep the branch open immediate and long-term!
    Antonio Colombo
    EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    J Invasive Cardiol 14:503-4. 2002
  89. ncbi Two-stent techniques for the treatment of coronary bifurcations with drug-eluting stents
    Ioannis Iakovou
    Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    Hellenic J Cardiol 46:188-98. 2005
  90. ncbi Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials
    Giuseppe G L Biondi-Zoccai
    Invasive Cardiology, San Raffaele Hospital, and EMO Centro Cuore Columbus, Milan, Italy
    Int J Cardiol 100:119-23. 2005
    ..Drug-eluting stents (DES) have been recently investigated, with favorable data for many devices, but comparative data are lacking. We thus performed an adjusted indirect comparison metaanalysis of DES...
  91. ncbi Crossing CTOs-the tips, tricks, and specialist kit that can mean the difference between success and failure
    Cosmo Godino
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
    Catheter Cardiovasc Interv 74:1019-46. 2009
    ..Finally, considering the greater risk of coronary perforation related to a CTO procedure compared to routine PCI, we describe which are best strategy and devices for treating coronary perforations and other major complications...
  92. ncbi Drug-eluting stent implantation in coronary trifurcation lesions
    Shinichi Furuichi
    San Raffaele Scientific Institute and EMO Centro Cuore Columbus, Milan, Italy
    J Invasive Cardiol 19:157-62. 2007
    ..There is no specific study evaluating the outcome of DES implantation in trifurcation lesions...
  93. ncbi Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation
    Hideo Takebayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 110:3430-4. 2004
    ..01 and P<0.01), minimum lumen area (P<0.01 and P<0.01), and IH thickness (P<0.01 and P<0.01). CONCLUSIONS: The number and distribution of stent struts affect the amount of neointima after SES implantation...
  94. ncbi Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome
    Angela Hoye
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 47:1949-58. 2006
    ..Furthermore, the incidence of possible stent thrombosis is of concern and requires further investigation. Kissing balloon post-dilatation is mandatory to reduce side branch restenosis...
  95. ncbi Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    JAMA 295:895-904. 2006
    ....
  96. ncbi Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II
    Sigmund Silber
    Cardiology Practice and Hospital, Munich, Germany
    Herz 29:171-80. 2004
    ..While predilatation was recommended per protocol, direct stenting was not forbidden: thus, direct stenting was performed in 49 patients (TAXUS n = 23, control n = 26)...
  97. ncbi IVUS guidance results in lower in-stent restenosis: A chapter for a history book?
    Antonio Colombo
    Catheter Cardiovasc Interv 59:322-3. 2003
  98. ncbi Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis
    Ricardo A Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    J Am Coll Cardiol 46:599-605. 2005
    ..CONCLUSIONS: In the majority of bifurcation lesions treated with the crush technique, the smallest minimum stent area appeared at the SB ostium. This may contribute to a higher restenosis rate at this location...
  99. ncbi A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
    Marie-Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    N Engl J Med 346:1773-80. 2002
    ..CONCLUSIONS: As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events...
  100. ncbi Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
    Sigmund Silber
    Kardiologische Praxis und Praxisklinik, Munchen, Germany
    Eur Heart J 26:804-47. 2005
    ....
  101. ncbi A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study
    Patrick W Serruys
    Erasmus University, Rotterdam, The Netherlands
    J Am Coll Cardiol 39:393-9. 2002
    ..We sought to investigate the clinical benefit of additional stent implantation after achieving an optimal result of balloon angioplasty (BA) in long coronary lesions (>20 mm)...